SCHEMBL3419701

SCHEMBL3419701

Brc1ccc(-c2cc3c4ccccc4c4ccccc4c3c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
GRM2 Q14416 1/20 0.44
TNKS O95271 2/20 0.39
ACHE P22303 1/20 0.36
MAOB P27338 2/20 0.35
PTPRC P08575 1/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1B1 Q16678 2/20 0.35
SLC6A3 Q01959 1/20 0.35
CYP1A2 P05177 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
PLK4 O00444 1/20 0.34
AURKA O14965 1/20 0.34
JAK2 O60674 1/20 0.34
LCK P06239 1/20 0.34
CDK1 P06493 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14328310 0.91 ALDH1A1 (0.42) ALDH1A1MAPK1GRM2TNKSACHE
SCHEMBL16558186 0.85 ALDH1A1 (0.58) ALDH1A1MAPK1GRM2TNKSACHE
SCHEMBL17915432 0.83 ALDH1A1 (0.33) ALDH1A1MAPK1GRM2CYP1A2
SCHEMBL29405243 0.83 ALDH1A1 (0.48) ALDH1A1MAPK1GRM2TNKSACHE
SCHEMBL2472443 0.80 GABRA1 (0.41) ALDH1A1MAOBCYP1A2NPC1RAB9A
SCHEMBL29596315 0.79 CYP11B1 (0.50) ALDH1A1MAPK1GRM2MAOBCYP1B1
SCHEMBL895891 0.79 CYP11B1 (0.50) ALDH1A1MAPK1GRM2MAOBCYP1B1
SCHEMBL3421191 0.79 ALDH1A1 (0.30) ALDH1A1CYP1A2
SCHEMBL3783118 0.78 CYP2A6 (0.47) ALDH1A1ACHECYP1A1CYP1B1CYP1A2
SCHEMBL23697444 0.78 CYP11B1 (0.49) ALDH1A1MAPK1GRM2MAOBCYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213640-B1 BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO (JP) 2016-10-05 EP disclosed
EP-2213640-B1 BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO (JP) 2016-10-05 EP disclosed
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 US disclosed
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 US disclosed
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 US disclosed
EP-2213640-A1 BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2010-08-04 EP disclosed
EP-2213640-A1 BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2010-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KSR1, NRAS, RSU1 ALDH1A1 466/4885MAPK1 106/4885GRM2 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.